about
Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cellsOncostatin M suppresses metastasis of lung adenocarcinoma by inhibiting SLUG expression through coordination of STATs and PIASs signalingsmiR-544a promotes the invasion of lung cancer cells by targeting cadherina 1 in vitroKrüppel-like factor 17 inhibits urokinase plasminogen activator gene expression to suppress cell invasion through the Src/p38/ MAPK signaling pathway in human lung adenocarcionmaDownregulation of GSK3β by miR-544a to maintain self-renewal ability of lung caner stem cells.Inferring relevant control mechanisms for interleukin-12 signaling in naïve CD4+ T cells.NOTCH1, HIF1A and other cancer-related proteins in lung tissue from uranium miners--variation by occupational exposure and subtype of lung cancerIL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axisConstructing lncRNA functional similarity network based on lncRNA-disease associations and disease semantic similarityAn important role for peroxiredoxin II in survival of A549 lung cancer cells resistant to gefitinib.RBMMMDA: predicting multiple types of disease-microRNA associations.Network biology of tumor stem-like cells identified a regulatory role of CBX5 in lung cancer.Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosisRespirology year-in-review 2007: Clinical science.Therapy-induced enrichment of putative lung cancer stem-like cells.Sustainability of CD24 expression, cell proliferation and migration, cisplatin-resistance, and caspase-3 expression during mesenchymal-epithelial transition induced by the removal of TGF-β1 in A549 lung cancer cells.Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line.MiR-145 regulates cancer stem-like properties and epithelial-to-mesenchymal transition in lung adenocarcinoma-initiating cells.Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.Anti-proliferative action of IL-6R-targeted antibody tocilizumab for non-small cell lung cancer cells.Mining featured micro ribonucleic acids associated with lung cancer based on bioinformatics.Metastasis-associated protein 2 (MTA2) promotes the metastasis of non-small-cell lung cancer through the inhibition of the cell adhesion molecule Ep-CAM and E-cadherin.
P2860
Q28473082-F43A29BC-B44E-4175-ACF2-46C41D9574A8Q28917131-33A9A9C1-BB31-4FD8-8F65-8532DDA5E9B7Q33734753-060DE11F-12D9-40E0-A517-B1F7FB866FE4Q33888940-D140786E-1FB7-4628-A40B-A1C86893BFBAQ34141601-6D3742F3-C56D-4368-9689-803C2F30622CQ34419693-9491E4A5-5023-4917-A8F8-C6F95488AC68Q34428676-71323317-5D0D-4915-B8E4-ADE46121E9FBQ35578377-67A38C60-E2AB-4694-902A-FA8E35115CFBQ35660195-40147715-1CDD-44E2-9059-541736AD595AQ35681515-66EC1E89-80A7-4BE8-96FE-C1EA9E237FABQ36034189-3E4A531A-62C6-4D16-919E-AB09907FB5A0Q36166708-E1219FB5-C899-46EE-B290-9EB543B855B8Q36579336-09B7506D-8E17-414F-BF3A-258E336AFA4BQ37109547-388A9CCB-0B02-44B5-9746-7EB82A0C1584Q38150766-90BC58F4-7919-47FD-9332-5BC023D47F21Q38695448-D283910F-6D4F-4B14-875F-47628C120998Q38709499-609E2814-5987-44EF-8789-583312E0F209Q38987801-F35D236F-6491-4739-9F50-32868D23DEDDQ39389192-E36FAFB7-6700-46FA-8D81-EEA6B51AFAEAQ39794629-BD9EA3FD-0C3C-4312-8C15-91B03C439BE4Q40774008-1DD79D76-3682-4801-8B7F-3E2667CB11B2Q42375406-AC3D40CA-EBC1-4160-945D-58B66ADB4B14Q51631755-6FC7E494-44B7-45B9-8558-DDADA99BA234
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Lung cancer: future directions.
@en
type
label
Lung cancer: future directions.
@en
prefLabel
Lung cancer: future directions.
@en
P2860
P1433
P1476
Lung cancer: future directions.
@en
P2093
D Neil Watkins
P2860
P304
P356
10.1111/J.1440-1843.2007.01105.X
P577
2007-07-01T00:00:00Z